Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Author Archives: Mission IR

Cardium Therapeutics Inc. (CXM) Announces $5.0 Million Financing With Institutional Investors

Posted on February 13, 2012 by Mission IR

Cardium Therapeutics today announced that it has entered into definitive agreements with three institutional and accredited investors to sell an aggregate of 17,857,143 shares of its common stock in a registered direct offering for gross proceeds of approximately $5.0 million, … Continue reading →

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Uranium Energy Corp (UEC) Completes Sale of Uranium

Posted on January 31, 2012 by Mission IR

Uranium Energy is pleased to announce the completion of a second uranium sale which will be reflected in the Company’s upcoming Fiscal 2012 Q2 report.  A further 60,000 pounds of U3O8 were sold for $52 per pound for gross proceeds … Continue reading →

Posted in Uranium Energy Corp. UEC | Leave a comment

Cardium Therapeutics Inc. (CXM) Presents New Generx Findings at 2012 Annual Gene and Cell Therapy Forum

Posted on January 30, 2012 by Mission IR

Cardium Therapeutics today reported on new insights and confirmatory preclinical study results on the Generx (Ad5FGF-4) angiogenic therapy product candidate based on the Company’s sponsored research conducted at Emory University.  The findings, which provide further support for the apparent safety … Continue reading →

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Uranium Energy Corp (UEC) to Acquire Cue Resources Ltd.

Posted on January 23, 2012 by Mission IR

Uranium Energy and Cue Resources Ltd. are pleased to announce that they have entered into an Arrangement Agreement under which UEC will acquire all of the outstanding common shares of CUE by way of a plan of arrangement (the “Arrangement”).  … Continue reading →

Posted in Uranium Energy Corp. UEC | Leave a comment

Biotechnology Industry on the Upswing – BioSante and Cardium Therapeutics Inc. (CXM) Look to Rally

Posted on January 17, 2012 by Mission IR

Biotechnology stocks have been on fire of late. The iShares Biotechnology index is up more than 12 percent over the last month as investors brace for big drug launches, FDA hearings, and greater M&A activity in the coming months. The … Continue reading →

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Cardium Therapeutics Inc. (CXM) Regains Listing Compliance With NYSE Amex

Posted on January 6, 2012 by Mission IR

Cardium Therapeutics today reported that it had received notice from NYSE Regulation that the Company is now considered to have regained compliance with the listing requirements of the NYSE Amex LLC (formerly the American Stock Exchange). (Logo:  http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO) In the … Continue reading →

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Cardium Therapeutics Inc. (CXM) Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen™ in South Korea

Posted on January 5, 2012 by Mission IR

Cardium Therapeutics today announced that it has entered into its first international agreement for the commercialization of Excellagen™ in the South Korean market. Cardium entered into a marketing and distribution agreement with BL&H Co. Ltd., an established pharmaceutical company based … Continue reading →

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Uranium Energy Corp (UEC) Issues Year-End Shareholder Report

Posted on January 4, 2012 by Mission IR

Uranium Energy today issued a Year-End Shareholder Report. The report from CEO Amir Adnani follows in its complete form: Dear Shareholder, As we begin a new year, I would like to provide for you a status report on the Company’s … Continue reading →

Posted in Uranium Energy Corp. UEC | Leave a comment

Cardium Therapeutics Inc. (CXM) to Present at Upcoming Investor Conferences

Posted on January 4, 2012 by Mission IR

Cardium Therapeutics today announced that it is scheduled to present at the Biotech Showcase 2012 and the 5th Annual OneMedForum Conference in San Francisco. (Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO) The 2012 Biotech Showcase is being held at the Parc 55 Wyndham in San … Continue reading →

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Cardium Therapeutics Inc. (CXM) Reports on Renewed Compliance With NYSE Amex Exchange Listing Guidelines

Posted on January 3, 2012 by Mission IR

Cardium Therapeutics Inc. today reported on its exchange listing compliance with NYSE Amex LLC (formerly the American Stock Exchange). The Company reports that its estimated stockholders’ equity is now in excess of the threshold requirements under Section 1003(a)(iii) of the … Continue reading →

Posted in Cardium Therapeutics Inc. CXM | Leave a comment